263 related articles for article (PubMed ID: 26831618)
1. Reversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system.
Fukuda S; Nishida-Fukuda H; Nanba D; Nakashiro K; Nakayama H; Kubota H; Higashiyama S
Sci Rep; 2016 Feb; 6():20209. PubMed ID: 26831618
[TBL] [Abstract][Full Text] [Related]
2. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.
Bade LK; Goldberg JE; Dehut HA; Hall MK; Schwertfeger KL
J Cell Sci; 2011 Sep; 124(Pt 18):3106-17. PubMed ID: 21868365
[TBL] [Abstract][Full Text] [Related]
3. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin.
Yang N; Morrison CD; Liu P; Miecznikowski J; Bshara W; Han S; Zhu Q; Omilian AR; Li X; Zhang J
Cell Cycle; 2012 Aug; 11(15):2922-30. PubMed ID: 22825057
[TBL] [Abstract][Full Text] [Related]
4. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.
Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z
Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154
[TBL] [Abstract][Full Text] [Related]
5. Role of EGF receptor ligands in TCDD-induced EGFR down-regulation and cellular proliferation.
Campion CM; Leon Carrion S; Mamidanna G; Sutter CH; Sutter TR; Cole JA
Chem Biol Interact; 2016 Jun; 253():38-47. PubMed ID: 27117977
[TBL] [Abstract][Full Text] [Related]
6. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
8. Amphiregulin induces CCN2 and fibronectin expression by TGF-β through EGFR-dependent pathway in lung epithelial cells.
Cheng WH; Kao SY; Chen CL; Yuliani FS; Lin LY; Lin CH; Chen BC
Respir Res; 2022 Dec; 23(1):381. PubMed ID: 36578010
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression.
Gao J; Ulekleiv CH; Halstensen TS
J Exp Clin Cancer Res; 2016 Sep; 35(1):151. PubMed ID: 27669890
[TBL] [Abstract][Full Text] [Related]
10. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
[TBL] [Abstract][Full Text] [Related]
11. Amphiregulin.
Berasain C; Avila MA
Semin Cell Dev Biol; 2014 Apr; 28():31-41. PubMed ID: 24463227
[TBL] [Abstract][Full Text] [Related]
12. EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation.
Joslin EJ; Opresko LK; Wells A; Wiley HS; Lauffenburger DA
J Cell Sci; 2007 Oct; 120(Pt 20):3688-99. PubMed ID: 17895366
[TBL] [Abstract][Full Text] [Related]
13. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.
Sternlicht MD; Sunnarborg SW
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):181-94. PubMed ID: 18470483
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
15. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
[TBL] [Abstract][Full Text] [Related]
16. Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells.
Tsai PC; Fu YS; Chang LS; Lin SR
Toxicon; 2016 Mar; 111():108-20. PubMed ID: 26774845
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells.
Huang Y; Chang Y; Wang X; Jiang J; Frank SJ
Endocrinology; 2004 Jul; 145(7):3297-306. PubMed ID: 15070853
[TBL] [Abstract][Full Text] [Related]
18. Specific N-glycan alterations are coupled in epithelial-mesenchymal transition induced by EGF in GE11 epithelial cells.
Xu Q; Qu C; Wang W; Gu J; Du Y; Song L
Cell Biol Int; 2017 Feb; 41(2):124-133. PubMed ID: 27888538
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
Wendt MK; Smith JA; Schiemann WP
Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523
[TBL] [Abstract][Full Text] [Related]
20. EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.
LeVea CM; Reeder JE; Mooney RA
Exp Cell Res; 2004 Jul; 297(1):272-84. PubMed ID: 15194442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
